keyword
Keywords Spindle assembly checkpoint ta...

Spindle assembly checkpoint targets

https://read.qxmd.com/read/37989391/high-comorbidity-of-pediatric-cancers-in-patients-with-birth-defects-insights-from-whole-genome-sequencing-analysis-of-copy-number-variations
#21
JOURNAL ARTICLE
Hui-Qi Qu, Joseph T Glessner, Jingchun Qu, Yichuan Liu, Deborah Watson, Xiao Chang, Amir Hossein Saeidian, Haijun Qiu, Frank D Mentch, John J Connolly, Hakon Hakonarson
BACKGROUND: Patients with birth defects (BD) exhibit an elevated risk of cancer. We aimed to investigate the potential link between pediatric cancers and BDs, exploring the hypothesis of shared genetic defects contributing to the coexistence of these conditions. METHODS: This study included 1454 probands with BDs (704 females and 750 males), including 619 (42.3%) with and 845 (57.7%) without co-occurrence of pediatric onset cancers. Whole genome sequencing (WGS) was done at 30X coverage through the Kids First/Gabriella Miller X01 Program...
November 19, 2023: Translational Research: the Journal of Laboratory and Clinical Medicine
https://read.qxmd.com/read/37963657/overexpression-of-jnk-associated-leucine-zipper-protein-induces-chromosomal-instability-through-interaction-with-dynein-light-intermediate-chain-1
#22
JOURNAL ARTICLE
Ryusuke Suzuki, Masato T Kanemaki, Takeshi Suzuki, Katsuji Yoshioka
The c-Jun N-terminal kinase-associated leucine zipper protein (JLP), a scaffold protein of mitogen-activated protein kinase signaling pathways, is a multifunctional protein involved in a variety of cellular processes. It has been reported that JLP is overexpressed in various types of cancer and is expected to be a potential therapeutic target. However, whether and how JLP overexpression affects non-transformed cells remain unknown. Here, we aimed to investigate the effect of JLP overexpression on chromosomal stability in human non-transformed cells and the mechanisms involved...
November 14, 2023: Genes to Cells: Devoted to Molecular & Cellular Mechanisms
https://read.qxmd.com/read/37934606/pp2a-inhibition-causes-synthetic-lethality-in-brca2-mutated-prostate-cancer-models-via-spindle-assembly-checkpoint-reactivation
#23
JOURNAL ARTICLE
Jian Wang, Yuke Chen, Shiwei Li, Wanchang Liu, Xiao Albert Zhou, Yefei Luo, Zhanzhan Xu, Yundong Xiong, Kaiqi Cheng, Mingjian Ruan, Wei Yu, Xiaoman Li, Weibin Wang, Jiadong Wang
Mutations in the BRCA2 tumor suppressor gene have been associated with an increased risk of developing prostate cancer. One of the paradoxes concerning BRCA2 is the fact that its inactivation affects genetic stability and is deleterious for cellular and organismal survival, while BRCA2-mutated cancer cells adapt to this detriment and malignantly proliferate. Therapeutic strategies for tumors arising from BRCA2 mutations may be discovered by understanding these adaptive mechanisms. In this study, we conducted forward genetic synthetic viability screenings in Caenorhabditis elegans brc-2 (Cebrc-2) mutants and found that Ceubxn-2 inactivation rescued the viability of Cebrc-2 mutants...
January 2, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/37745348/reviving-immunogenic-cell-death-upon-targeting-tacc3-enhances-t-dm1-response-in-her2-positive-breast-cancer
#24
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Caliskan, Erden Banoglu, Stefan Wiemann, Aysegul Uner, Sercan Aksoy, Shikhar Mehrotra, Ozgur Sahin
UNLABELLED: Immunogenic cell death (ICD), an immune-priming form of cell death, has been shown to be induced by several different anti-cancer therapies. Despite being the first and one of the most successful antibody-drug conjugates (ADCs) approved for refractory HER2-positive breast cancer, little is known if response and resistance to trastuzumab emtansine (T-DM1) involves ICD modulation that can be leveraged to enhance T-DM1 response. Here, we report that T-DM1 induces spindle assembly checkpoint (SAC)-dependent ICD in sensitive cells by inducing eIF2α phosphorylation, surface exposure of calreticulin, ATP and HMGB1 release, and secretion of ICD-related cytokines, all of which are lost in resistance...
September 14, 2023: bioRxiv
https://read.qxmd.com/read/37705955/inhibition-of-the-serine-threonine-kinase-bub1-reverses-taxane-resistance-in-prostate-cancer
#25
JOURNAL ARTICLE
Maria J Martinez, Rolando D Z Lyles, Nahuel Peinetti, Alex M Grunfeld, Kerry L Burnstein
Men with incurable castration resistant prostate cancer (CRPC) are typically treated with taxanes; however, drug resistance rapidly develops. We previously identified a clinically relevant seven gene network in aggressive CRPC, which includes the spindle assembly checkpoint (SAC) kinase BUB1. Since SAC is deregulated in taxane resistant PC, we evaluated BUB1 and found that it was over-expressed in advanced PC patient datasets and taxane resistant PC cells. Treatment with a specific BUB1 kinase inhibitor re-sensitized resistant CRPC cells, including cells expressing constitutively active androgen receptor (AR) variants, to clinically used taxanes...
September 15, 2023: IScience
https://read.qxmd.com/read/37663116/mcl-1-deficiency-in-murine-livers-leads-to-nuclear-polyploidisation-and-mitotic-errors-implications-for-hepatocellular-carcinoma
#26
JOURNAL ARTICLE
Laure-Alix Clerbaux, Pierre Cordier, Nina Desboeufs, Kristian Unger, Peter Leary, Gabriel Semere, Yannick Boege, Lap Kwan Chan, Chantal Desdouets, Massimo Lopes, Achim Weber
BACKGROUND & AIMS: Mcl-1, an antiapoptotic protein overexpressed in many tumours, including hepatocellular carcinoma (HCC), represents a promising target for cancer treatment. Although Mcl-1 non-apoptotic roles might critically influence the therapeutic potential of Mcl-1 inhibitors, these functions remain poorly understood. We aimed to investigate the effects of hepatic Mcl-1 deficiency (Mcl-1Δhep ) on hepatocyte ploidy and cell cycle in murine liver in vivo and the possible implications on HCC...
October 2023: JHEP reports: innovation in hepatology
https://read.qxmd.com/read/37639469/genetic-enhancers-of-partial-plk1-inhibition-reveal-hypersensitivity-to-kinetochore-perturbations
#27
JOURNAL ARTICLE
Karine Normandin, Jasmin Coulombe-Huntington, Corinne St-Denis, Alexandre Bernard, Mohammed Bourouh, Thierry Bertomeu, Mike Tyers, Vincent Archambault
Polo-like kinase 1 (PLK1) is a serine/threonine kinase required for mitosis and cytokinesis. As cancer cells are often hypersensitive to partial PLK1 inactivation, chemical inhibitors of PLK1 have been developed and tested in clinical trials. However, these small molecule inhibitors alone are not completely effective. PLK1 promotes numerous molecular and cellular events in the cell division cycle and it is unclear which of these events most crucially depend on PLK1 activity. We used a CRISPR-based genome-wide screening strategy to identify genes whose inactivation enhances cell proliferation defects upon partial chemical inhibition of PLK1...
August 2023: PLoS Genetics
https://read.qxmd.com/read/37625527/perspectives-and-mechanisms-for-targeting-mitotic-catastrophe-in-cancer-treatment
#28
REVIEW
Zhaoshi Bai, Yiran Zhou, Yaling Peng, Xinyue Ye, Lingman Ma
Mitotic catastrophe is distinct from other cell death modes due to unique nuclear alterations characterized as multi and/or micronucleation. Mitotic catastrophe is a common and virtually unavoidable consequence during cancer therapy. However, a comprehensive understanding of mitotic catastrophe remains lacking. Herein, we summarize the anticancer drugs that induce mitotic catastrophe, including microtubule-targeting agents, spindle assembly checkpoint kinase inhibitors, DNA damage agents and DNA damage response inhibitors...
August 23, 2023: Biochimica et Biophysica Acta. Reviews on Cancer
https://read.qxmd.com/read/37509260/cdc20-is-regulated-by-the-histone-methyltransferase-kmt5a-in-castration-resistant-prostate-cancer
#29
JOURNAL ARTICLE
Zainab A H Alebady, Mahsa Azizyan, Sirintra Nakjang, Emma Lishman-Walker, Dhuha Al-Kharaif, Scott Walker, Hui Xian Choo, Rebecca Garnham, Emma Scott, Katya L Johnson, Craig N Robson, Kelly Coffey
The methyltransferase KMT5A has been proposed as an oncogene in prostate cancer and therefore represents a putative therapeutic target. To confirm this hypothesis, we have performed a microarray study on a prostate cancer cell line model of androgen independence following KMT5A knockdown in the presence of the transcriptionally active androgen receptor (AR) to understand which genes and cellular processes are regulated by KMT5A in the presence of an active AR. We observed that 301 genes were down-regulated whilst 408 were up-regulated when KMT5A expression was reduced...
July 13, 2023: Cancers
https://read.qxmd.com/read/37475576/targeting-the-loss-of-cgas-sting-signaling-in-cancer
#30
REVIEW
Nobunari Sasaki, Mizuki Homme, Shunsuke Kitajima
The cGAS/STING pathway provides a key host defense mechanism by detecting the accumulation of cytoplasmic double-stranded DNA (dsDNA) and mediating innate and adaptive immune signaling. In addition to detecting pathogen-derived dsDNA, cGAS senses intrinsic dsDNA, such as those associated with defective cell cycle progression and mitophagy that has leaked from the nucleus or mitochondria, and subsequently evokes host immunity to eliminate pathogenic cells. In cancer cells, dysregulation of DNA repair and cell cycle caused at the DNA replication checkpoint and spindle assembly checkpoint results in aberrant cytoplasmic dsDNA accumulation, stimulating anti-tumor immunity...
July 20, 2023: Cancer Science
https://read.qxmd.com/read/37468549/camk2d-serves-as-a-molecular-scaffold-for-rnf8-mad2-complex-to-induce-mitotic-checkpoint-in-glioma
#31
JOURNAL ARTICLE
You Heng Chuah, Emmy Xue Yun Tay, Oleg V Grinchuk, Jeehyun Yoon, Jia Feng, Srinivasaraghavan Kannan, Matius Robert, Rekha Jakhar, Yajing Liang, Bernice Woon Li Lee, Loo Chien Wang, Yan Ting Lim, Tianyun Zhao, Radoslaw M Sobota, Guang Lu, Boon Chuan Low, Karen Carmelina Crasta, Chandra Shekhar Verma, Zhewang Lin, Derrick Sek Tong Ong
MAD2 is a spindle assembly checkpoint protein that participates in the formation of mitotic checkpoint complex, which blocks mitotic progression. RNF8, an established DNA damage response protein, has been implicated in mitotic checkpoint regulation but its exact role remains poorly understood. Here, RNF8 proximity proteomics uncovered a role of RNF8-MAD2 in generating the mitotic checkpoint signal. Specifically, RNF8 competes with a small pool of p31comet for binding to the closed conformer of MAD2 via its RING domain, while CAMK2D serves as a molecular scaffold to concentrate the RNF8-MAD2 complex via transient/weak interactions between its p-Thr287 and RNF8's FHA domain...
July 19, 2023: Cell Death and Differentiation
https://read.qxmd.com/read/37443114/bid-expression-determines-the-apoptotic-fate-of-cancer-cells-after-abrogation-of-the-spindle-assembly-checkpoint-by-aurkb-or-ttk-inhibitors
#32
JOURNAL ARTICLE
Jordi Bertran-Alamillo, Ana Giménez-Capitán, Ruth Román, Sara Talbot, Rebecca Whiteley, Nicolas Floc'h, Elizabeth Martínez-Pérez, Matthew J Martin, Paul D Smith, Ivana Sullivan, Mikkel G Terp, Jamal Saeh, Cristina Marino-Buslje, Giulia Fabbri, Grace Guo, Man Xu, Cristian Tornador, Andrés Aguilar-Hernández, Noemí Reguart, Henrik J Ditzel, Alejandro Martínez-Bueno, Núria Nabau-Moretó, Amaya Gascó, Rafael Rosell, J Elizabeth Pease, Urszula M Polanska, Jon Travers, Jelena Urosevic, Miguel A Molina-Vila
BACKGROUND: Drugs targeting the spindle assembly checkpoint (SAC), such as inhibitors of Aurora kinase B (AURKB) and dual specific protein kinase TTK, are in different stages of clinical development. However, cell response to SAC abrogation is poorly understood and there are no markers for patient selection. METHODS: A panel of 53 tumor cell lines of different origins was used. The effects of drugs were analyzed by MTT and flow cytometry. Copy number status was determined by FISH and Q-PCR; mRNA expression by nCounter and RT-Q-PCR and protein expression by Western blotting...
July 13, 2023: Molecular Cancer
https://read.qxmd.com/read/37346953/new-cyclic-glycolipids-from-silene-succulenta-promote-in-vitro-mcf-7-breast-carcinoma-cell-apoptosis-by-cell-cycle-arrest-and-in-silico-mitotic-mps1-ttk-inhibition
#33
JOURNAL ARTICLE
Sarah A Badawy, Ahmed R Hassan, Rawah H Elkousy, Salwa A Abu El Wafa, Abd-El Salam I Mohammad
In vitro anticancer screening of Silene succulenta Forssk. aerial parts (Caryophyllaceae) showed that the n -hexane fraction was a highly effective fraction against breast carcinoma cell lines (MCF-7) with IC50 = 15.5 μg mL-1 . The bioactive-guided approach led to the isolation of two new cyclic glucolipids from the n -hexane fraction, identified as a 1,2'-cyclic ester of 11-oxy-(6'- O -acetyl-β-d-glucopyranosyl) behenic acid (1) as a C-11 epimeric mixture and 11( R )-oxy-(β-d-glucopyranosyl)-1,2'-cyclic ester of behenic acid (2)...
June 15, 2023: RSC Advances
https://read.qxmd.com/read/37293018/cul3-substrate-adaptor-spop-targets-nup153-for-degradation
#34
Joseph Y Ong, Jorge Z Torres
SPOP is a Cul3 substrate adaptor responsible for degradation of many proteins related to cell growth and proliferation. Because mutation or misregulation of SPOP drives cancer progression, understanding the suite of SPOP substrates is important to understanding regulation of cell proliferation. Here, we identify Nup153, a component of the nuclear basket of the nuclear pore complex, as a novel substrate of SPOP. SPOP and Nup153 bind to each other and colocalize at the nuclear envelope and some nuclear foci in cells...
May 30, 2023: bioRxiv
https://read.qxmd.com/read/37256347/genetic-heterogeneity-in-p53-null-leukemia-increases-transiently-with-spindle-assembly-checkpoint-inhibition-and-is-not-rescued-by-p53
#35
JOURNAL ARTICLE
Mai Wang, Steven Phan, Brandon H Hayes, Dennis E Discher
Chromosome gains or losses often lead to copy number variations (CNV) and loss of heterozygosity (LOH). Both quantities are low in hematologic "liquid" cancers versus solid tumors in data of The Cancer Genome Atlas (TCGA) that also shows the fraction of a genome affected by LOH is ~ one-half of that with CNV. Suspension cultures of p53-null THP-1 leukemia-derived cells conform to these trends, despite novel evidence here of genetic heterogeneity and transiently elevated CNV after perturbation...
May 31, 2023: Chromosoma
https://read.qxmd.com/read/37183646/-progress-in-the-study-of-spindle-assembly-checkpoint-in-lung-cancer
#36
JOURNAL ARTICLE
Xinchen Qin, Yao Zhang, Haijie Yu, Lijuan Ma
Spindle assembly checkpoint (SAC) is a protective mechanism for cells to undergo accurate mitosis. SAC prevented chromosome segregation when kinetochores were not, or incorrectly attached to microtubules in the anaphase of mitosis, thus avoiding aneuploid chromosomes in daughter cells. Aneuploidy and altered expression of SAC component proteins are common in different cancers, including lung cancer. Therefore, SAC is a potential new target for lung cancer therapy. Five small molecule inhibitors of monopolar spindle 1 (MPS1), an upstream component protein of SAC, have entered clinical trials...
April 20, 2023: Zhongguo Fei Ai za Zhi, Chinese Journal of Lung Cancer
https://read.qxmd.com/read/37163344/budding-uninhibited-by-benzimidazoles-1-might-be-a-poor-prognosis-biomarker-promoting-the-progression-of-papillary-thyroid-cancer
#37
JOURNAL ARTICLE
Wenjie Jiang, Yan Yu, Adheesh Bhandari, Suzita Hirachan, Xubin Dong, Xiaoli Huang, Jinmiao Qu, Chengze Chen
BACKGROUND: Papillary thyroid carcinoma (PTC) is one of the most widespread malignant tumors of the endocrine system, with a high incidence. Budding uninhibited by benzimidazoles 1 (BUB1), one of the spindle assembly checkpoint (SAC) genes, is a multitask protein kinase required for eukaryotic chromosome segregation. Although BUB1 has been explored in several types of cancer, its biological role and molecular mechanisms in PTC remain unclear. METHODS: In this study, we performed an examination of four public datasets along with local PTC cohorts and discovered that BUB1 was elevated in PTC compared to non-cancer tissues...
May 10, 2023: Environmental Toxicology
https://read.qxmd.com/read/37138483/recent-updates-on-oncogenic-signaling-of-aurora-kinases-in-chemosensitive-chemoresistant-cancers-novel-medicinal-chemistry-approaches-for-targeting-aurora-kinases
#38
JOURNAL ARTICLE
Pooja Kumara, Narasimha M Beeraka, Anandkumar Tengli, Gurupadayya Bm, Ramandeep Kaur, Mayuri Patil
The Aurora Kinase family (AKI) is composed of serine-threonine protein kinases involved in the modulation of the cell cycle and mitosis. These kinases are required for regulating the adherence of hereditary-related data. Members of this family can be categorized into aurora kinase A (Ark-A), aurora kinase B (Ark-B), and aurora kinase C (Ark-C), consisting of highly conserved threonine protein kinases. These kinases can modulate cell processes such as spindle assembly, checkpoint pathway, and cytokinesis during cell division...
May 3, 2023: Current Medicinal Chemistry
https://read.qxmd.com/read/37100900/alternative-cdc20-translational-isoforms-tune-mitotic-arrest-duration
#39
JOURNAL ARTICLE
Mary-Jane Tsang, Iain M Cheeseman
Mitotic defects activate the spindle-assembly checkpoint, which inhibits the anaphase-promoting complex co-activator CDC20 to induce a prolonged cell cycle arrest1,2 . Once errors are corrected, the spindle-assembly checkpoint is silenced, allowing anaphase onset to occur. However, in the presence of persistent unresolvable errors, cells can undergo 'mitotic slippage', exiting mitosis into a tetraploid G1 state and escaping the cell death that results from a prolonged arrest. The molecular logic that enables cells to balance these duelling mitotic arrest and slippage behaviours remains unclear...
April 26, 2023: Nature
https://read.qxmd.com/read/37067150/bub-1-and-cenp-c-recruit-plk-1-to-control-chromosome-alignment-and-segregation-during-meiosis-i-in-c-elegans-oocytes
#40
JOURNAL ARTICLE
Samuel J P Taylor, Laura Bel Borja, Flavie Soubigou, Jack Houston, Dhanya K Cheerambathur, Federico Pelisch
Phosphorylation is a key post-translational modification that is utilised in many biological processes for the rapid and reversible regulation of protein localisation and activity. Polo-like kinase 1 (PLK-1) is essential for both mitotic and meiotic cell divisions, with key functions being conserved in eukaryotes. The roles and regulation of PLK-1 during mitosis have been well characterised. However, the discrete roles and regulation of PLK-1 during meiosis have remained obscure. Here, we used Caenorhabditis elegans (C...
April 17, 2023: ELife
keyword
keyword
92900
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.